跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 104,911 条关于
“PARP 1/2”
全部
104,911
临床试验
69,580
药物
12,249
机构
2,505
资讯
20,577
去年
Senaparib Approved in China for First-Line Maintenance Therapy in Ovarian Cancer
9个月前
Zai Lab Secures Reimbursement Renewal for Three Key Therapies in China's 2025 National Drug List
4年前
Combination Immunotherapies Show Promise in Pancreatic Cancer Treatment
去年
GSK Launches First PD-1 Immunotherapy and PARP Inhibitor for Gynecological Cancers in India
24天前
Combination of JAK2 and PARP Inhibitors Shows Early Promise in Phase 1 Trial for Myelofibrosis
11年前
PARP Inhibitors Show Promise in Epithelial Ovarian and Breast Cancers with BRCA1/2 Mutations
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
9个月前
FoRx Therapeutics Secures $50M Series A to Advance PARG Inhibitor for PARP-Resistant Cancers
9个月前
CU Anschutz Launches First-in-Class Phase 1 Trial Combining PARP Inhibitor with Novel WNT Pathway Modulator for Resistant Ovarian Cancer
4年前
PARP Inhibitors Show Promise in Ovarian Cancer Maintenance Therapy
第 1 页,共 2058 页
上一页
下一页